Bortezomib For Injection (2018-04-18)

Bortezomib for Injection Recall Bortezomib for Injection has been recalled across Canada due to product safety concerns. This is a Class I recall, which indicates a serious safety issue. The recall affects bortezomib injection products distributed throughout Canada.

Reason
Product safety
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2018-04-19
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/3164fc2c-da66-44cb-95f7-62cc9c772a0e